Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.38 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.38 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.38 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.38 |
| ▸ | PYGB | P11216 | 3/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | OGA | O60502 | 5/20 | 0.33 |
| ▸ | HEXA | P06865 | 1/20 | 0.33 |
| ▸ | HEXB | P07686 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13957969 | 0.91 | LGALS1 (0.42) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL24496738 | 0.86 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL10182892 | 0.86 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL13010059 | 0.86 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL24618835 | 0.86 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL388615 | 0.86 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL10111771 | 0.86 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL22059921 | 0.86 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL22854031 | 0.86 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL12113351 | 0.86 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8PYGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9057088-B2 | Biologically active silver-coated proteins | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2015-06-16 | — | — | US | disclosed |
| US-20090291070-A1 | Biologically Active Silver-Coated Proteins | RAMOT AT TEL AVIV UNIVERYSITY LTD. (IL) | 2009-11-26 | — | — | US | disclosed |
| EP-1520583-B1 | NKT cell-activating agents containing alpha-glycosylceramides | KYOWA HAKKO KIRIN CO LTD (JP) | 2009-01-28 | — | — | EP | disclosed |
| EP-1605039-B1 | DENDRITIC CELL PRESENTING ALPHA-GLYCOSYLCERAMIDE DERIVATIVE AND A NTIGEN AND USABLE IN SUPPRESSING IMMUNE RESPONSE | KIRIN PHARMA KK (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090291070-A1 | Biologically Active Silver-Coated Proteins | THEM6, PPP6C, LPO | LGALS1 124/4885LGALS3 232/4885LGALS9 144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.